XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Stock Awards
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11.
STOCK AWARDS
 
In accordance with the Company’s
2013
Incentive Plan, stock awards, including stock options and restricted stock, have been granted to certain employees and non-employee directors. Shares of common stock available for distribution to satisfy the grants
may
consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner. Stock-based compensation expense related to stock awards totaled
$0.1
million for both of the
six
-month periods ended
June 30, 2018
and
2017.
 
Stock Options
 
Stock option awards have been granted with an exercise price equal to the market price of the Company’s common stock on the date of the grant and have vesting periods ranging from
one
to
three
years, with
10
-year contractual terms. 
 
The Company recognizes the cost of services received in exchange for stock option awards based on the grant date fair value of the award, with compensation expense recognized on a straight-line basis over the award’s vesting period. The fair value of outstanding awards was determined using the Black-Scholes option pricing model based on the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock
.
 
   
2018
   
2017
 
Risk-free interest rate    
2.77
%    
2.23
%
Expected term (in years)    
7.5
     
7.5
 
Expected stock price volatility    
28.3
%    
25.4
%
Dividend yield    
1.50
%    
1.50
%
 
The following table summarizes the Company's stock option activity for the periods presented.
 
   
Six
Months Ended
 
   
June 30
, 2018
   
June 30
, 2017
 
   
Number of
Shares
   
Average
Exercise
Price
   
Number of
Shares
   
Average
Exercise
Price
 
Options:
                               
Outstanding, beginning of period
   
318,000
    $
9.43
     
272,550
    $
8.21
 
Granted
   
62,150
     
11.71
     
68,600
     
13.91
 
Exercised
   
     
     
19,316
     
8.15
 
Expired
   
     
     
     
 
Forfeited
   
1,450
     
11.05
     
3,333
     
11.79
 
Options outstanding, end of period
   
378,700
    $
9.80
     
318,501
    $
9.41
 
Options exercisable, end of period
   
249,300
    $
8.71
     
208,633
    $
8.20
 
 
The aggregate intrinsic value of stock options outstanding (calculated as the
amount by which the market value of underlying stock exceeds the exercise price of the option) was approximately
$0.9
million and
$0.8
million as of
June 30, 2018
and 
2017,
respectively.
 
Restricted Stock
 
During the
first
six
months of
2018
and
2017,
respectively,
10,520
shares and
7,533
shares of restricted stock were granted. The Company recognizes the cost of services received in exchange for restricted stock awards based on the grant date closing price of the stock, with compensation expense recognized on a straight-line basis over the award’s vesting period.